Ocular aftermath of Stevens-Johnson syndrome.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001768:Blister / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D003228:Conjunctiva / Q000473:pathology; D003231:Conjunctivitis / Q000150:complications*; D003315:Cornea / Q000473:pathology; D003318:Corneal Opacity / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007634:Keratitis / Q000209:etiology*; D008027:Light; D008297:Male; D009264:Nails, Malformed / Q000209:etiology / Q000473:pathology; D013256:Steroids / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D014787:Vision Tests; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D013256:Steroids